Published • loading... • Updated
Labcorp Launches RNA-Based At-Home Colorectal Cancer Test Nationwide
Summary by Clinical Lab Products
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Labcorp Launches RNA-Based At-Home Colorectal Cancer Test Nationwide
The test detect signs of colorectal cancer and precancerous growths using a home collection kit. Labcorp announced the nationwide availability of ColoSense, an RNA-based at-home screening test for colorectal cancer approved by the Food and Drug Administration (FDA). Offered through a commercial collaboration with test developer Geneoscopy, the test expands Labcorp’s range of colorectal cancer screening solutions. The test is now covered for elig…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
